MITF and lung adenocarcinoma: In contrast to melanoma patients, lung adenocarcinoma (LUAD) patients with high MITF expression had longer survival time than those with low MITF expression (p < 0.05, log-rank test) (Figure 5B and Supplementary Table 5).